MedPath

Effect of sesame oil in treatment of non-alcoholic fatty liver

Phase 3
Recruiting
Conditions
on-alcoholic fatty liver.
Fatty (change of) liver, not elsewhere classified
K76.0
Registration Number
IRCT20140208016529N6
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
56
Inclusion Criteria

Willingness to participate in the study
Female
Being 20 to 50 years old
Having Non-alcoholic fatty liver disease
Routine consumption of sunflower oil
Body mass index between 25 and 40

Exclusion Criteria

Participate in other studies in the last 6 months
Having weight loss plans in the last three months
Having a special diet in the last three months
Smoking
Being menopausal
Having a history of breast cancer
Insulin consumption
Having allergies
Having other liver diseases except non-alcoholic fatty liver
Having hereditary hemochromatosis
Having serious diseases such as cancer, cholangitis sclerosis, kidney failure, autoimmunity, malignancies, celiac disease
Consumption of mineral multivitamin and omega-3 supplements in the past month
Consumption of drugs that effects on the level of liver enzymes of ALP, AST and ALT
Consumption of drugs that cause fatty liver
Using hepatotoxicity drugs
Alcohol consumption
Pregnancy
Lactation
Having hormone-dependent cysts
Having Wilson's disease

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Fatty liver grade. Timepoint: Before intervention and 12 weeks after intervention. Method of measurement: Liver sonography.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath